CoCo Therapeutics is a United Kingdom-based biotechnology company formed in 2013 jointly by King's College London, the Wellcome Trust and Advent Venture Partners. The company will focus on development of therapeutics for Alzheimer's disease which target retinoic acid receptor alpha, specifically building on work originating in the Neuroscience Drug Discovery Unit of King's College, led by Jonathan Corcoran. This work was funded through the Wellcome Trust's Seeding Drug Discovery Initiative.
Attributes | Values |
---|---|
rdf:type |
|
rdfs:label |
|
rdfs:comment |
|
foaf:name |
|
foaf:homepage | |
name |
|
dcterms:subject | |
Wikipage page ID |
|
Wikipage revision ID |
|
Link from a Wikipage to another Wikipage |
|
Link from a Wikipage to an external page | |
sameAs | |
dbp:wikiPageUsesTemplate | |
foundation |
|
industry | |
location country |
|
has abstract |
|
gold:hypernym | |
prov:wasDerivedFrom | |
page length (characters) of wiki page |
|
founding year |
|
industry | |
foaf:isPrimaryTopicOf | |
is Link from a Wikipage to another Wikipage of | |
is foaf:primaryTopic of |